115 related articles for article (PubMed ID: 29455030)
41. VEGFR2 regulates endothelial differentiation of colon cancer cells.
Liu Z; Qi L; Li Y; Zhao X; Sun B
BMC Cancer; 2017 Aug; 17(1):593. PubMed ID: 28854900
[TBL] [Abstract][Full Text] [Related]
42. PINCH-2 presents functional copy number variation and suppresses migration of colon cancer cells by paracrine activity.
Park CH; Rha SY; Ahn JB; Shin SJ; Kwon WS; Kim TS; An S; Kim NK; Yang WI; Chung HC
Int J Cancer; 2015 May; 136(10):2273-83. PubMed ID: 25346044
[TBL] [Abstract][Full Text] [Related]
43. NDC80 promotes proliferation and metastasis of colon cancer cells.
Xing XK; Wu HY; Chen HL; Feng HG
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173328
[TBL] [Abstract][Full Text] [Related]
44. Absence of mutation at the 5'-upstream promoter region of the TPM4 gene from cardiac mutant axolotl (Ambystoma mexicanum).
Denz CR; Zhang C; Jia P; Du J; Huang X; Dube S; Thomas A; Poiesz BJ; Dube DK
Cardiovasc Toxicol; 2011 Sep; 11(3):235-43. PubMed ID: 21626230
[TBL] [Abstract][Full Text] [Related]
45. Comparative Proteomics Analysis Identifies Cdc42-Cdc42BPA Signaling as Prognostic Biomarker and Therapeutic Target for Colon Cancer Invasion.
Hu HF; Xu WW; Wang Y; Zheng CC; Zhang WX; Li B; He QY
J Proteome Res; 2018 Jan; 17(1):265-275. PubMed ID: 29072916
[TBL] [Abstract][Full Text] [Related]
46. Clinical significance and prognostic value of Nek2 protein expression in colon cancer.
Lu L; Zhai X; Yuan R
Int J Clin Exp Pathol; 2015; 8(11):15467-73. PubMed ID: 26823916
[TBL] [Abstract][Full Text] [Related]
47. Expression of interleukine-8 as an independent prognostic factor for sporadic colon cancer dissemination.
Nastase A; Paslaru L; Herlea V; Ionescu M; Tomescu D; Bacalbasa N; Dima S; Popescu I
J Med Life; 2014 Jun; 7(2):215-9. PubMed ID: 25408728
[TBL] [Abstract][Full Text] [Related]
48. Mutations in tropomyosin 4 underlie a rare form of human macrothrombocytopenia.
Pleines I; Woods J; Chappaz S; Kew V; Foad N; Ballester-Beltrán J; Aurbach K; Lincetto C; Lane RM; Schevzov G; Alexander WS; Hilton DJ; Astle WJ; Downes K; Nurden P; Westbury SK; Mumford AD; Obaji SG; Collins PW; Delerue F; Ittner LM; Bryce NS; Holliday M; Lucas CA; Hardeman EC; Ouwehand WH; Gunning PW; Turro E; Tijssen MR; Kile BT
J Clin Invest; 2017 Mar; 127(3):814-829. PubMed ID: 28134622
[TBL] [Abstract][Full Text] [Related]
49. miR-378 suppresses the proliferation, migration and invasion of colon cancer cells by inhibiting SDAD1.
Zeng M; Zhu L; Li L; Kang C
Cell Mol Biol Lett; 2017; 22():12. PubMed ID: 28725241
[TBL] [Abstract][Full Text] [Related]
50. Prognostic significance of downregulated expression of the candidate tumour suppressor gene SASH1 in colon cancer.
Rimkus C; Martini M; Friederichs J; Rosenberg R; Doll D; Siewert JR; Holzmann B; Janssen KP
Br J Cancer; 2006 Nov; 95(10):1419-23. PubMed ID: 17088907
[TBL] [Abstract][Full Text] [Related]
51. The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer.
Stein U; Arlt F; Walther W; Smith J; Waldman T; Harris ED; Mertins SD; Heizmann CW; Allard D; Birchmeier W; Schlag PM; Shoemaker RH
Gastroenterology; 2006 Nov; 131(5):1486-500. PubMed ID: 17101323
[TBL] [Abstract][Full Text] [Related]
52. Expression of tropomyosin 2 gene isoforms in human breast cancer cell lines.
Dube S; Thomas A; Abbott L; Benz P; Mitschow C; Dube DK; Poiesz BJ
Oncol Rep; 2016 Jun; 35(6):3143-50. PubMed ID: 27108600
[TBL] [Abstract][Full Text] [Related]
53. The clinical significance and biological function of olfactomedin 4 in triple negative breast cancer.
Xiong B; Lei X; Zhang L; Fu J
Biomed Pharmacother; 2017 Feb; 86():67-73. PubMed ID: 27939521
[TBL] [Abstract][Full Text] [Related]
54. Rare missense variants in Tropomyosin-4 (TPM4) are associated with platelet dysfunction, cytoskeletal defects, and excessive bleeding.
Stapley RJ; Poulter NS; Khan AO; Smith CW; Bignell P; Fratter C; Lester W; Lowe G; Morgan NV;
J Thromb Haemost; 2022 Feb; 20(2):478-485. PubMed ID: 34758189
[TBL] [Abstract][Full Text] [Related]
55. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
Chen R; Zhu J; Dong Y; He C; Hu X
Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
[TBL] [Abstract][Full Text] [Related]
56. Clinical Characterization and Prognostic Value of TPM4 and Its Correlation with Epithelial-Mesenchymal Transition in Glioma.
Wang J; Yang Y; Du B
Brain Sci; 2022 Aug; 12(9):. PubMed ID: 36138856
[TBL] [Abstract][Full Text] [Related]
57. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
Zhang W; He W; Shi Y; Zhao J; Liu S; Zhang F; Yang J; Xie C; Zhang Y
Int J Oncol; 2017 Jan; 50(1):173-184. PubMed ID: 27909716
[TBL] [Abstract][Full Text] [Related]
58. miRNA-185 serves as a prognostic factor and suppresses migration and invasion through Wnt1 in colon cancer.
Zhang W; Sun Z; Su L; Wang F; Jiang Y; Yu D; Zhang F; Sun Z; Liang W
Eur J Pharmacol; 2018 Apr; 825():75-84. PubMed ID: 29454608
[TBL] [Abstract][Full Text] [Related]
59. KRAS mutation associated with CD44/CD166 immunoexpression as predictors of worse outcome in metastatic colon cancer.
Ribeiro KB; da Silva Zanetti J; Ribeiro-Silva A; Rapatoni L; de Oliveira HF; da Cunha Tirapelli DP; Garcia SB; Feres O; da Rocha JJ; Peria FM
Cancer Biomark; 2016 Mar; 16(4):513-21. PubMed ID: 27062566
[TBL] [Abstract][Full Text] [Related]
60. Specific microRNA-mRNA Regulatory Network of Colon Cancer Invasion Mediated by Tissue Kallikrein-Related Peptidase 6.
Sells E; Pandey R; Chen H; Skovan BA; Cui H; Ignatenko NA
Neoplasia; 2017 May; 19(5):396-411. PubMed ID: 28431272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
